- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
ENTOD Pharma launches under eye gel serum Eyecirque in India
Eyecirque is available online and in selected pharmacies & doctor's clinics.
Mumbai: ENTOD Pharmaceuticals has recently announced that the company has developed nanotechnology-based Eyecirque under eye gel serum in collaboration with the UK based cosmetic research laboratory NuSkin London.
Based on an innovative plant-based bio cellular formula containing vitamin A+ C+ E complex, anti-aging antioxidants, skin brightening agents and naturally occurring ultra-moisturizing ingredients, the gel gets easily absorbed into the skin around the eyes.
"Its nanotechnology-based bio cellular formula contains carefully curated, safety tested, and scientifically proven plant-based natural ingredients that are thoroughly tested for the safety of the skin around the eyes," the company stated.
"The sensitive area underneath our eyes definitely needs some extra attention and care. Sleepless nights, stress and much more can lead to eye bags, dark circles and more, particularly highlighting that targeted area. Therefore, our team has come up with Eyecirque under eye gel serum, which is the world's first nanotechnology based under eye gel serum formulated with scientifically proven natural ingredients that are thoroughly tested for safety on the skin around the eyes. Results can be seen as early as a couple of weeks within application. However, one needs to use it for at least 6 weeks in order to start seeing significant improvements and continue to boost the skin around your eyes in the long run," said Mr. Nikkhil K Masurkar, Executive Director, ENTOD Pharmaceuticals.
"Through nanotechnology, ingredients have undergone an advanced particle size reduction process to give particle sizes of less than 50 nanometres. Such extremely small potent nano-particles are absorbed almost 20 times better and faster into the skin providing deeper skin penetration. This allows for greater spread across the target skin site and significantly improved bioavailability leading to quicker and more prominent results. Our researchers have designed this technology specially for the delicate skin around the eyes after thorough dermatological and ophthalmological testing," said Anjula Masurkar, Clinical Director, ENTOD International Group.
Eyecirque is available online and in selected pharmacies & doctor's clinics.
Read also: Entod Pharma gets DCGI nod for phase 3 trials of Atropine eye drops
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751